Human T Cell Responses Induced by Vaccination with Mycobacterium bovis Bacillus Calmette-Guérin

Journal of Immunology

Volumn 158, Issue 4, 1997, Pages 1949-1955

  Ravn, Pernille ^a   Boesen, Henriette ^a   Pedersen, Bente Klarlund ^b   Andersen, Peter ^a  

^a STATENS SERUM INSTITUT   (Denmark)

^b University of Copenhagen   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIAL ANTIGEN; BCG VACCINE; CYTOKINE; EPITOPE;

ADOLESCENT; ADULT; ARTICLE; BIOSYNTHESIS; CD4+ T LYMPHOCYTE; CELL CULTURE; CLINICAL TRIAL; CYTOTOXICITY; FEMALE; HUMAN; IMMUNOLOGY; LYMPHOCYTE ACTIVATION; MALE; METABOLISM; MYCOBACTERIUM BOVIS; T LYMPHOCYTE; TH1 CELL;

ADOLESCENT; ADULT; ANTIGENS, BACTERIAL; BCG VACCINE; CD4-POSITIVE T-LYMPHOCYTES; CELLS, CULTURED; CYTOKINES; CYTOTOXICITY, IMMUNOLOGIC; EPITOPES; FEMALE; HUMANS; LYMPHOCYTE ACTIVATION; MALE; MYCOBACTERIUM BOVIS; T-LYMPHOCYTES; TH1 CELLS;

EID: 0031568551     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (55)

1. Colditz, G. A., T. F. Brewer, C. S. Berkey, M. E. Wilson, E. F. Burdick, H. V. Fineberg, and H. V. F. Mosteller. 1994. Efficacy of BCG vaccine in the prevention of tuberculosis: meta-analysis of the published literature. JAMA 271:698.
2. Colditz, G. A., C. S. Berkey, F. Mosteller, T. F. Brewer, M. E. Wilson, E. Burdick, and H. V. Fineberg. 1995. The efficacy of bacillus Calmette-Guérin vaccination of newborns and infants in the prevention of tuberculosis: meta-analysis of the published literature. Pediatrics 96:29.
3. Rodrigues, L. C., V. K. Diwan, and J. G. Wheeler. 1993. Protective effect of BCG against tuberculous meningitis and miliary tuberculosis: a meta-analysis. Int. J. Epidemiol. 22:1154.
4. Fine, P. E. M. 1995. Variations in protection by BCG: implications of and for heterologous immunity. Lancet 346:1339.
5. Al-Kassimi, F. A., M. S. Al-Hajjaj, I. O. Al-Orainey, and E. A. Bamgboye. 1995. Does the protective effect of neonatal BCG correlate with vaccine-induced tuberculin reaction? Am. J. Respir. Crit. Care Med. 152:1575.
6. Fine, P. E. M., J. A. C. Sterne, J. M. Pönnighaus, and R. J. W. Rees. 1994. Delayed-type hypersensitivity, mycobacterial vaccines and protective immunity. Lancet 344:1245.
7. ten Dam, H. G. 1984. Research on BCG vaccination. Am. J. Respir. Crit. Care Med. 21:79.
8. Youmans, G. P. 1975. Relation between delayed hypersensitivity and immunity in tuberculosis. Am. Rev. Respir. Dis. 111:109.
9. Palmer, C. E. and M. W. Long. 1966. Effects of infection with atypical mycobacteria on BCG vaccination and tuberculosis. Am. Rev. Respir. Dis. 94.4:553.
10. Sjögren, I. 1976. Tuberculosis in BCG-vaccinated and unvaccinated young Swedish men: a comparative study. Scand. J. Respir. Dis. 57:208.
11. Springett, V. H., and I. Sutherland. 1994. A re-examination of the variations in the efficacy of BCG vaccination against tuberculosis in clinical trials. Tubercle Lung Dis. 75:2277.
12. Stanford, J. L., M. J. Shield, and G. A. W. Rook. 1981. Hypothesis 1. How environmental mycobacteria may predetermine the protective efficacy of BCG. Tubercle 62:55.
13. Rook, G. A. W., G. M. Bahr, and J. L. Stanford. 1981. Hypothesis 2. The effect of two distinct forms of cell-mediated response to mycobacteria on the protective efficacy of BCG. Tubercle 62:63.
14. Egsmose, T. 1965. BCG vaccination with special emphasis on the feasibility of vaccinating also tuberculin positive persons and of using the vaccination lesion as an indicator of tuberculous infection. Acta Tuberc. Scand. 46:220.
15. Nielsen, E. 1953. BCG vaccinationen med redegørelse for erfaringer fra Bornholm. Doctoral thesis, University Hospital of Copenhagen, Copenhagen, Denmark. Fyns Stifts Bogtrykkeri.
16. Castes, M., J. Blackwell, D. Trujillo, S. Formica, M. Cabrera, G. Zorrilla, A. Rodas, P. L. Castellanos, and J. Convit. 1994. Immune response in healthy volunteers vaccinated with killed leishmanial promastigotes plus BCG. I: skin-test reactivity, T-cell proliferation and interferon production. Vaccine 12:1041.
17. Pabst, H. F., C. J. Godel, D. W. Spady, J. Mckehnie, and M. Grace. 1989. Prospective trial of timing bacillus Calmette-Guérin vaccination in Canadian Cree infants. Am. Rev. Respir. Dis. 140:1007.
18. Cheng, S. H., K. B. Walker, D. B. Lowrie, D. A. Mitchison, R. Swamy, M. Datta, and R. Prabhakar. 1993. Monocyte antimycobacterial activity before and after Mycobacterium bovis BCG vaccination in Chingleput, India, and London, United Kingdom. Infect. Immun. 61:4501.
19. Andersen, P. 1994. Effective vaccination of mice against Mycobacterium tuberculosis with a soluble mixture of secreted mycobacterial proteins. Infect. Immun. 62:2536.
20. Horwitz M. A., B. E. Lee, J. B. Dillon, and G. Hart. 1995. Protective immunity against tuberculosis induced by vaccination with extracellular proteins of Mycobacterium tuberculosis. Proc. Natl. Acad. Sci. 92:1530.
21. Roberts, A. D., M. G. Sonnenberg, D. J. Ordway, P. J. Furney, P. J. Brennan, J. T. Belisle, and I. M. Orme. 1995. Characteristics of protective immunity of protective immunity engendered by vaccination of mice with purified culture filtrate antigens of Mycobacterium tuberculosis. Immunology 85:502.
22. Pal, P. G, and M. A. Horwitz. 1992. Immunization with extracellular proteins of Mycobacterium tuberculosis induces cell-mediated immune responses and substantial protective immunity in a guinea pig model of pulmonary tuberculosis. Infect. Immun. 60:4781.
23. Guleria, I., R. Teitelbaum, R. McAdam, G. Kalpana, W. R. Jacobs, and B. R. Bloom, Jr. 1996. Auxotrophic vaccines for tuberculosis. Nat. Med. 3:334.
24. Lanckriet, C., D. Levy Bruhl, E. Bingono, R. M. Siopathis, and N. Guérin. 1995. Efficacy of BCG vaccination of the newborn: evaluation by follow-up study of contacts in Bangui. Int. J. Epidemiol. 24:1042.
25. Miceli, I., I. N. DeKantor, D. Colaiácovo, G. Peluffo, I. Cutillo, R. Gorra, R. Botta, S. Hom, and H. G. ten Dam. 1988. Evaluation of the effectiveness of BCG vaccination using the case control method in Buenos Aires, Argentina. Int. J. Epidemiol. 17:629.
26. Myint, T. T., H. Win, H. H. Aye, and T. O. Kyaw-Mint. 1987. Case-control study on evaluation of BCG vaccination of newborn in Rangoon. Burma. Ann. Trop. Paediatr. 7:159.
27. Packe, G. E., and J. A. Innes. 1988. Protective effect of BCG vaccination in infant Asians: a case control study. Arch. Dis. Child. 63:277.
28. Tidiani, O., A. Amedome, and H. G. ten Dam. 1986. The protective effect of BCG vaccination of the newborn against childhood tuberculosis in an African community. Tubercle 67:269.
29. Sørensen, A. L., S. Nagai, G. Houen, P. Andersen, and Å. B. Andersen. 1995. Purification and characterization of a low-molecular-mass T-cell antigen secreted by Mycobacterium tuberculosis. Infect. Immun. 63.5:1710.
30. Andersen, P., D. Askgaard, L. Ljungqvist, J. Bennedsen, and I. Heron. 1991. Proteins released from Mycobacterium tuberculosis during growth. Infect. Immun. 59:1905.
31. Andersen, P., and I. Heron. 1993. Simultaneous electroelution of whole SDS-polyacrylamide gels for the direct cellular analysis complex protein mixtures. J. Immunol. Methods 161:29.
32. Brandt, L., T. Oettinger, A. Holm, and P. Andersen. 1996. Key epitopes on the secreted ESAT-6 antigen recognized in mice during recall of protective immunity to Mycobacterium tuberculosis. J. Immunol. 157:3527.
33. + HLA-DR-restricted cytotoxic T lymphocytes as well as non-specific nonrestricted killer cells by the recombinant mycobacterial 65-kDa heat shock protein. Eur. J. Immunol. 20:369.
34. Kumararatne, D. S., A. S. Pithie, P. Drysdale, J. S. H. Gaston, R. Kiessling, P. B. Iles, C. J. Ellis, J. Innes, and R. Wise. 1990. Specific lysis of mycobacterial antigen-bearing macrophages by class II MHC restricted polyclonal T cell lines in healthy donors or patients with tuberculosis. Clin. Exp. Immunol. 80:314.
35. Andersen, P., D. Askgård, L. Ljungquist, M. W. Bentzon, and I. Heron. 1991. T-cell proliferative response to antigens secreted by Mycobacterium tubcerculosis. Infect. Immun. 59:1558.
36. Orme, I. M., E. S. Miller, A. D. Roberts, S. K. Furney, J. P. Griffin, K. M. Dobos, D. Chi, B. Rivoire, and P. J. Brennan. 1992. T lymphocytes mediating protection and cellular cytolysis during the course of Mycobacterium tubcerculosis infection: evidence for different kinetics and recognition of a wide spectrum of protein antigens. J. Immunol. 148:189.
37. Boesen, H., B. N. Jensen, T. Wilcke, and P. Andersen. 1995. Human T-cell responses to secreted antigen fractions of Mycobacterium tuberculosis. Infect. Immun. 63:1491.
38. Andersen, P., Å. B. Andersen, A. L. Sørensen, and S. Nagai. 1995. Recall of long lived immunity to Mycobacterium tuberculosis infection in mice. J. Immunol 154:3359.
39. Orme, I. M., P. Andersen, and W. H. Boom. 1993. T cell response to Mycobacterium tuberculosis. J. Infect. Dis. 167:1481.
40. Daugelat, S., H. Gulle, and B. Schoel. 1992. Secreted antigens from Mycobacterium tuberculosis: characterisation with T lymphocytes from patients and contacts after two-dimensional separation. J. Infect. Dis. 166:186.
41. Havlir, D. V., R. S. Wallis, W. H. Boom, T. M. Daniel, K. Chervenak, and J. J. Ellner. 1991. Human immune response to Mycobacterium tuberculosis antigens. Infect. Immun. 59:665.
42. Harboe, M., T. Oettinger, H. G. Wiker, I. Rosenkrands, and P. Andersen. 1996. Evidence for occurence of the ESAT-6 protein in Mycobacterium tuberculosis and virulent Mycobacterium bovis and for its absence in Mycobacterium bovis BCG. Infect. Immun. 64:16.
43. Aronson, J. D. 1948. Protective vaccination against tuberculosis with special reference to BCG vaccination. Am. Rev. Tuberc. 58:255.
44. Dahlström, G. 1953. Tuberculosis in BCG vaccinated and non-vaccinated young adults: a comparative prognostic study. Acta. Tuberc. Scand. Suppl. 32.
45. Hart, P. D. A., and I. Sutherland. 1977. BCG and vole bacillus vaccines in the prevention of tuberculosis in adolescence and early adult life: final report to the Medical Research Council. Br. Med. J. 1977 ii:293.
46. Flynn, J. L., J. Chan, K. J. Triebold, D. K. Dalton, T. A. Stewart, and B. R. Bloom. 1993. An essential role for interferon in resistance to Mycobacterium tuberculosis infection. J. Exp. Med. 178:2249.
47. Cooper, A. M., D. K. Dalton, T. A. Stewart, J. P. Griffen, D. G. Russel, and I. M. Orme. 1993. Disseminated tuberculosis in interferon-gamma gene-disrupted mice. J Exp. Med. 178:2243.
48. + T lymphocytes in intracellular microbial infections. Immunol. Today 9:168.
49. + T lymphocyte subpopulation in tuberculous pleuritis. J. Immunol. 142:1114.
50. Lorgat, F., M. M. Keraan, and S. R. Ress. 1992. Cellular immunity in tuberculous pleural effusions: evidence of spontaneous lymphocyte proliferation and antigen-specific accelerated responses to purified protein derivative (PPD). Clin. Exp. Immunol. 90:215.
51. Forte, M., G. Maartens, M. Rahelu, J. Pasi, C. Ellis, H. Gaston, and D. Kumarartne. 1992. Cytolytic T-cell activity against mycobacterial antigens in HIV. AIDS 6:407.
52. + lymphocytes from healthy HIV seropositive and seronegative individuals. J. Acquired Immune Defic. Syndr. Hum. Retrovirol. 12:433.
53. Hahn, S., R. Gehri, and P. Erb. 1995. Mechanism and biological significance of CD4-mediated cytotoxicity. Immunol. Rev. 146:57.
54. Falkinheim, J. O., B. C. Parker, H. Gruft. 1980. Epidemiology of infection with nontuberculous mycobacteria. I. Geographical distribution in the Eastern United States. Am. Rev. Respir. Dis. 121:931.
55. Tuberculosis Prevention Trial Madras. 1980. Trial of BCG vaccination in South India for tuberculosis prevention. Ind. Med. Res. 72(Suppl.):1.